Literature DB >> 25096485

Aberrant transcriptional regulation could explain phenotypic variability in autosomal recessive polycystic kidney disease.

Friedrich C Luft1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25096485     DOI: 10.1007/s00109-014-1197-3

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  15 in total

Review 1.  Mechanisms of alternative pre-messenger RNA splicing.

Authors:  Douglas L Black
Journal:  Annu Rev Biochem       Date:  2003-02-27       Impact factor: 23.643

Review 2.  Pre-messenger RNA processing and its regulation: a genomic perspective.

Authors:  M Soller
Journal:  Cell Mol Life Sci       Date:  2006-04       Impact factor: 9.261

3.  Nephrectomy in an autosomal recessive polycystic kidney disease (ARPKD) patient with rapid kidney enlargement and increased expression of EGFR.

Authors:  Anja Arbeiter; Rainer Büscher; Klaus-Eugen Bonzel; Anne-Margret Wingen; Udo Vester; Jeremias Wohlschläger; Klaus Zerres; Jens Nürnberger; Carsten Bergmann; Peter F Hoyer
Journal:  Nephrol Dial Transplant       Date:  2008-05-23       Impact factor: 5.992

4.  Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes.

Authors:  Kian Huat Lim; Luciana Ferraris; Madeleine E Filloux; Benjamin J Raphael; William G Fairbrother
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-17       Impact factor: 11.205

5.  Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD).

Authors:  Carsten Bergmann; Jan Senderek; Ellen Windelen; Fabian Küpper; Iris Middeldorf; Frank Schneider; Christian Dornia; Sabine Rudnik-Schöneborn; Martin Konrad; Claus P Schmitt; Tomas Seeman; Thomas J Neuhaus; Udo Vester; Jutta Kirfel; Reinhard Büttner; Klaus Zerres
Journal:  Kidney Int       Date:  2005-03       Impact factor: 10.612

6.  Adaptable molecular interactions guide phosphorylation of the SR protein ASF/SF2 by SRPK1.

Authors:  Jonathan C Hagopian; Chen-Ting Ma; Bryan R Meade; Claudio P Albuquerque; Jacky Chi Ki Ngo; Gourisankar Ghosh; Patricia A Jennings; Xiang-Dong Fu; Joseph A Adams
Journal:  J Mol Biol       Date:  2008-07-26       Impact factor: 5.469

Review 7.  Genotype-phenotype correlations in autosomal dominant and autosomal recessive polycystic kidney disease.

Authors:  Sandro Rossetti; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2007-04-11       Impact factor: 10.121

8.  The translational landscape of the splicing factor SRSF1 and its role in mitosis.

Authors:  Magdalena M Maslon; Sara R Heras; Nicolas Bellora; Eduardo Eyras; Javier F Cáceres
Journal:  Elife       Date:  2014-05-06       Impact factor: 8.140

9.  Increasing the Coding Potential of Genomes Through Alternative Splicing: The Case of PARK2 Gene.

Authors:  Valentina La Cognata; Rosario Iemmolo; Velia D'Agata; Soraya Scuderi; Filippo Drago; Mario Zappia; Sebastiano Cavallaro
Journal:  Curr Genomics       Date:  2014-06       Impact factor: 2.236

10.  Alternative isoform regulation in human tissue transcriptomes.

Authors:  Eric T Wang; Rickard Sandberg; Shujun Luo; Irina Khrebtukova; Lu Zhang; Christine Mayr; Stephen F Kingsmore; Gary P Schroth; Christopher B Burge
Journal:  Nature       Date:  2008-11-27       Impact factor: 49.962

View more
  1 in total

Review 1.  Three-dimensional regulation of transcription.

Authors:  Jun Cao; Zhengyu Luo; Qingyu Cheng; Qianlan Xu; Yan Zhang; Fei Wang; Yan Wu; Xiaoyuan Song
Journal:  Protein Cell       Date:  2015-02-12       Impact factor: 14.870

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.